UNSPSC 51263314: Trigevolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L2D8DE8S32. European Medicines Agency schedules Trigevolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11294MIG. Trigevolol generally arises in the molecular formula C21H28N2O7.

UNSPSC 51263314 Trigevolol, a Commodity code, does not align with the state and local procurement activity tagged under it. The single recent opportunity on record — Seminole County, Florida's IFB60459723LAS for naloxone and safe drug deactivation systems — falls outside the pharmaceutical ingredient scope that the code's name suggests. The mismatch indicates either a classification error in the source record or that trigevolol is not being actively procured by state and local governments at present. No other recent state or local solicitations under this code are available to characterize actual buying patterns, issuing-body mix, or geographic spread.

The Seminole County procurement is a community health initiative unrelated to trigevolol itself. Without additional opportunities under the code, no reliable market characterization is possible. Firms evaluating this code should verify its accuracy against their target jurisdictions' actual purchasing activity before committing business development resources.